An interventional study of Intervention Group in Abdominal Obesity, sponsored by Pennington Biomedical Research Center. Completed at 1 site in United States. Open to participants aged 18 Years to 64 Years. Per ClinicalTrials.gov, last updated 2024-12-19.
Sponsored by Pennington Biomedical Research Center · Not applicable, Interventional, and Prevention
The purpose of the WorkACTIVE-P study is to assess the outcome of an innovative multi-component intervention focused on increasing energy expenditure and re-balancing the disrupted energy balance equation of sedentary workplaces with an ultimate target of reducing workers' abdominal obesity.
The energy expenditure intervention includes replacing workplace sedentary time with access to a dedicated pedal desk and increasing steps/day with wearable monitors. Both components are incorporated into an electronically-delivered behavior monitoring and support infrastructure, thus enabling continuous management. The investigators will utilize pedaldesks manufactured and owned by Pennington Biomedical Research Center to conduct this study at Blue Cross Blue Shield of Louisiana offices in Baton Rouge, La. 40 individuals will be recruited and randomized to either a control arm or combined Walk More Pedal Desk (WMPD) intervention. Primary (MRI-determined visceral adipose tissue) and secondary (changes in body weight, total adipose tissue, subcutaneous adipose tissue, blood pressure, blood lipids, fasting glucose and insulin, HbA1-c, free-living accelerometer-determined walking, time spent in sedentary behavior, exercise, and dietary intake) outcomes will be assessed at baseline and month 3.
274 studies on the registry are indexed under Obesity, Abdominal; 44 are open to participants now.
This study's enrollment of 40 is below the median of 60 across 216 interventional studies indexed under Obesity, Abdominal.
Browse Obesity, Abdominal studies →Pennington Biomedical Research Center is the lead sponsor of 277 studies on the registry; 29 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
* Usual Working Condition Group (UWC) * The no-intervention control condition will be asked to maintain their usual work and lifestyle throughout the study. Participants may be contacted by Pennington Biomedical staff during the intervention.
* Combined Intervention (Walk More and Pedal Desk; WMPD) * Participants in the WMPD condition will engage in both step-counting (Walk More, WM) and pedal desk (PD) intervention components.
Behavioral: Intervention Group
The content of both intervention components will be covered during a weekly scheduled group meeting (or face-to-face meetings, as needed). The step-counting component of the WMPD intervention will be modeled off the success of The First Step Program (FSP).
Also known as: Walk More and Pedal Desk Group, WMPD
Change in Visceral Adipose Tissue (VAT), Measured in kg
Change (end of study minus baseline) in abdominal obesity operationalized as MRI-determined visceral adipose tissue (VAT) and measured in kg.
Time frame: 3 -month-long controlled trial
Changes in Body Weight
Weight will be measured to the nearest 0.1 kg using a standard stadiometer.
Time frame: 3-month-long controlled trial
| Milestone | Control Group | Intervention Group |
|---|---|---|
| Started | 20 | 20 |
| Completed | 20 | 20 |
| Not completed | 0 | 0 |
Change (end of study minus baseline) in abdominal obesity operationalized as MRI-determined visceral adipose tissue (VAT) and measured in kg.
| kg | Control Group | Intervention Group |
|---|---|---|
| Change in Visceral Adipose Tissue (VAT), Measured in kg | .04 (-0.07 to 0.15) | -0.10 (-0.22 to 0.01) |
Weight will be measured to the nearest 0.1 kg using a standard stadiometer.
| kg | Control Group | Intervention Group |
|---|---|---|
| Changes in Body Weight | -0.3 (-1.3 to 0.6) | -0.9 (-1.8 to 0.1) |
Collected over 3 months. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Control Group | 0/20 (0%) | 0/20 (0%) | 0/20 (0%) |
| Intervention Group | 0/20 (0%) | 0/20 (0%) | 0/20 (0%) |
| Age, Continuous(years) | Control Group | Intervention Group | Total |
|---|---|---|---|
| Mean | 46.7 ± 9.8 | 46.2 ± 11.4 | 46.4 ± 10.5 |
| Sex: Female, Male(Participants) | Control Group | Intervention Group | Total |
|---|---|---|---|
| Female | 14 | 17 | 31 |
| Male | 6 | 3 | 9 |
| Race (NIH/OMB)(Participants) | Control Group | Intervention Group | Total |
|---|---|---|---|
| American Indian or Alaska Native | 0 | 0 | 0 |
| Asian | 0 | 0 | 0 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 |
| Black or African American | 5 | 7 | 12 |
| White | 15 | 13 | 28 |
| More than one race | 0 | 0 | 0 |
| Unknown or Not Reported | 0 | 0 | 0 |
| Weight(kg) | Control Group | Intervention Group | Total |
|---|---|---|---|
| Mean | 86.1 ± 14.0 | 89.6 ± 16.6 | 87.7 ± 15.14 |
Documents are hosted by the registry — open the source record to download them.
Plan to share: No
This study is completed, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Pennington Biomedical Research Center